Related Experiment Video
Updated: Feb 15, 2026
09:45
An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
Published on: May 21, 2019
9.0K
miFAST: A novel and rapid microRNA target capture method
Ashley M Poenitzsch Strong1, Scott M Berry2, David J Beebe2
1Department of Dermatology, University of Wisconsin-Madison, Madison, Wisconsin.
Molecular Carcinogenesis
|January 20, 2018
Summary
Researchers developed miFAST, a new method to identify direct microRNA (miRNA) targets. This technique confirmed known miR-340 targets and discovered new ones in melanoma, advancing miRNA research.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- MicroRNAs (miRNAs) are small non-coding RNAs crucial for cellular and tumor biology.
- Identifying direct miRNA targets is challenging due to numerous predicted targets and experimental limitations.
Purpose of the Study:
- To develop a novel technique for identifying direct miRNA target genes.
- To validate the technique's efficacy in confirming known targets and discovering novel ones.
Main Methods:
- Development of a new methodology named miFAST (microRNA direct target identification FAST).
- Application of miFAST to identify direct targets of miR-340 in melanoma cells.
Main Results:
- miFAST successfully confirmed previously reported direct miR-340 target genes.
- Five novel direct miR-340 targets were identified in melanoma cells.
- The methodology demonstrated efficiency for global miRNA target characterization.
Conclusions:
- The miFAST technique provides an efficient way to identify direct miRNA targets.
- Characterizing direct miRNA targetomes using miFAST enhances understanding of miRNA biology and function.
- This approach has implications for cancer research and therapeutic development.
Related Concept Videos
01:22MicroRNAs
24.3K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.3K
01:22MicroRNAs
4.1K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.1K
01:24Rapidly Varying Flow
518
Rapidly varying flow (RVF) in open channels is characterized by abrupt changes in flow depth over a short distance, with the rate of depth change relative to distance often approaching unity. These flows are inherently complex due to their transient and multi-dimensional nature, making exact analysis difficult. However, approximate solutions using simplified models provide valuable insights into their behavior.Key Features of Rapidly Varying FlowRVF is commonly observed in scenarios involving...
518
02:57Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
02:35RACE - Rapid Amplification of cDNA Ends
7.3K
Rapid Amplification of cDNA Ends, or RACE, is one of the most effective methods to obtain a full-length cDNA from an mRNA sequence between a known internal region to the unknown sequence at the 5’ or 3’ end. The unknown region is cloned in the cDNA by a gene-specific primer that binds the known end, and a hybrid primer that attaches a predefined anchor sequence to the unknown end of the cDNA. The sequence in between is amplified by PCR with an anchor primer and a gene-specific...
7.3K
01:26Targets for Drug Action: Overview
10.6K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.6K